戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                              ICL confers an increased risk of opportunistic infection
2                                              ICL predisposes patients to severe opportunistic infecti
3                                              ICL repair requires unhooking of the tethered strands by
4                                              ICL-1 utilizes a bioinspired endoperoxide trigger to rel
5                                              ICL-labeled cells disappeared from blood almost immediat
6                                              ICLs are produced upon irradiation under anoxic conditio
7                                              ICLs are thought to be processed by proteins from a vari
8  characterization of iron-caged luciferin-1 (ICL-1), a bioluminescent probe that enables longitudinal
9 emain unclear.METHODSWe hybridized 34 and 51 ICL patients' sera to a 9,000-human-proteome array and t
10  of autoantibodies from the sera of 51 adult ICL patients (out of a cohort of 72).
11 causes genetic instability without affecting ICL repair.
12 e angle narrowing was detected 1 month after ICL V4c implant, this narrowing remained stable at 3 mon
13 1 month, 3 months, 1 year, and 2 years after ICL implant.
14 95% CI, 10.1%-25.8%) at 5 and 10 years after ICL implantation, respectively.
15 pment and refractive outcomes 10 years after ICL implantation.
16 ms establishes base excision as an alternate ICL repair pathway in bacteria.
17 cterized Escherichia coli protein YcaQ as an ICL repair glycosylase that protects cells against the t
18                         BRCA2 function at an ICL protects against DNA2-WRN nuclease-helicase complex
19 tivated when a replication fork stalls at an ICL(2); this triggers monoubiquitination of the ID compl
20 t NEIL3 to replication forks converged at an ICL, but the nature of DNA binding and the effect of the
21 niscent of a replication fork arrested at an ICL.
22  mutants display towards mechlorethamine, an ICL-inducing compound.
23 the structure and extent of processing of an ICL, its bypass may not absolutely require TLS polymeras
24  vivo from DNA replication fork bypass of an ICL.
25     When a replication fork collides with an ICL, it triggers a damage response that promotes multipl
26 -ZF domain on catalysis of base excision and ICL unhooking is unknown.
27  pathways (BER, MMR, NER, NHEJ, HR, TLS, and ICL repair) are specifically discussed for inhibitor dis
28 umulation of CSB at sites of monoadducts and ICLs, but it did not affect recruitment to (although sli
29 glycosylase activity against monoadducts and ICLs.
30 hooks both sides of symmetric and asymmetric ICLs in vitro, and loss or overexpression of ycaQ sensit
31 nd resection and homologous recombination at ICL damage.
32 A2 is necessary for the protection of DNA at ICLs.
33 te can unhook either or both sides of an AZB ICL, providing a basis for understanding the mechanisms
34  of the available patient information before ICL implantation.
35 recognition and the Fanconi anemia (FA)-BRCA ICL repair network.
36 siae, a vestigial FA pathway is present, but ICLs are predominantly repaired by a pathway involving t
37 FANCD2 proteins that subsequently coordinate ICL removal and repair of the ensuing DNA double-strande
38 acts, we describe here a replication-coupled ICL repair pathway that does not require incisions or FA
39 for the repair of DNA interstrand crosslink (ICL) damage.
40 s that participate in interstrand crosslink (ICL) DNA repair and MEC differentiation control.
41                   DNA interstrand crosslink (ICL) repair requires a complex network of DNA damage res
42 plication-coupled DNA interstrand crosslink (ICL) repair, the XPF-ERCC1 endonuclease is required for
43 ecombination (HR) and interstrand crosslink (ICL) repair.
44 tion primarily in DNA interstrand crosslink (ICL) repair.
45  genes regulating DNA interstrand crosslink (ICL) repair.
46 itrogen mustard-based interstrand crosslink (ICL) with an 8-atom linker between the crosslinked bases
47 ancer cell line to interstrand-crosslinking (ICL) agents.
48 or the repair of DNA interstrand crosslinks (ICL) and related lesions(1).
49 been shown to unhook interstrand crosslinks (ICL) in Xenopus extracts, how NEIL3 participants in ICL
50 or the repair of DNA interstrand crosslinks (ICL), a highly toxic lesion that leads to chromosomal in
51 or the repair of DNA interstrand crosslinks (ICL).
52 on and repair of DNA interstrand crosslinks (ICL).
53                  Interstrand DNA crosslinks (ICLs) are a toxic form of DNA damage that block DNA repl
54 in the repair of DNA interstrand crosslinks (ICLs) and regulates cellular responses to replication st
55 in the repair of DNA interstrand crosslinks (ICLs) are associated with the genome instability syndrom
56                  DNA interstrand crosslinks (ICLs) are generated by endogenous sources and chemothera
57                      Interstrand crosslinks (ICLs) are highly toxic DNA lesions that are repaired via
58                      Interstrand crosslinks (ICLs) are toxic DNA lesions that cause severe genomic da
59 umor agents form DNA interstrand crosslinks (ICLs), but their clinical efficiency is counteracted by
60 osslinks, especially interstrand crosslinks (ICLs), cause cytotoxicity via blocking replication and t
61 emotherapy cause DNA interstrand crosslinks (ICLs), which covalently link both strands of the double
62 ersensitivity to DNA interstrand crosslinks (ICLs).
63 damage, specifically interstrand crosslinks (ICLs).
64 ducts and trioxsalen interstrand crosslinks (ICLs).
65  optical cavity operating with a 3.29 mum cw ICL is detailed, and a quantitative characterization of
66 gher accumulation of the extremely cytotoxic ICLs and DSBs lesions, which in turn triggers the induct
67 ted benzyl cations alkylated dG, dC, and dA, ICL assay with variation of DNA sequences showed that th
68 pon ICL induction, suggesting that defective ICL repair causes karyomegaly.
69 s (KIN), but it is unclear whether defective ICL repair is responsible or whether Fan1 nuclease activ
70 ng, differentiated state, as well as delayed ICL processing as revealed by a modified Comet assay and
71 D2, and Merit40-null cells exhibited delayed ICL unhooking coupled with reduced end resection and hom
72 cted T-lymphocyte cell line Jurkat delivered ICLs to the BM more efficiently than erythrocytes, and m
73 i and NEIL1 excise unhooked psoralen-derived ICLs in three-stranded DNA via hydrolysis of the glycosi
74 ike DNA glycosylases unhook psoralen-derived ICLs in various DNA structures via a genuine repair mech
75 ne the FA pathway signaling required for DNA ICL repair and genome stability.
76 tment of FAN1 to ICLs or for its role in DNA ICL resistance.
77  Interestingly, Merit40 mutation exacerbated ICL-induced chromosome instability in the context of con
78 ycosylase that protects its host by excising ICLs derived from azinomycin B (AZB), a potent antimicro
79                                    Following ICL implant, corresponding values fell to 31.2 +/- 11.5,
80 roteins act in a linear hierarchy: following ICL detection on chromatin, the FA core complex monoubiq
81 age and is most rapid and robust as follows: ICLs>DSBs>monoadducts>oxidative lesions.
82 ential use as an immunotherapeutic agent for ICL.
83 al of 107 eyes from 56 patients assessed for ICL implantation at our institution were included in the
84 ld serve to identify suitable candidates for ICL placement.
85         The SIMs of SLX4 are dispensable for ICL repair but important for processing CPT-induced repl
86 ment of Fan1 by Ub-Fancd2 is dispensable for ICL repair.
87 of a favorable architectural environment for ICL repair processing.
88    Monoubiquitination of ID is essential for ICL repair by excision, translesion synthesis and homolo
89 rug Administration's accepted guidelines for ICL sizing, clinicians should be aware of and account fo
90 o stalled replication forks is important for ICL repair.
91 and interaction with BRCA1 are important for ICL resistance when RAP80 is deficient.
92  (FA) pathway is the principal mechanism for ICL repair in metazoans and is coupled to DNA replicatio
93 itinated ID complex loses its preference for ICL and related branched DNA structures, and becomes a s
94         The Fan1 nuclease, also required for ICL repair, is recruited to ICLs by ubiquitinated (Ub) F
95 extender DNA polymerase is also required for ICL repair.
96  mice, we show that Trp53 is responsible for ICL-induced bone marrow failure and that loss of Trp53 i
97  myopic subjects consecutively scheduled for ICL implant, FDOCT (RTVue; Optovue Inc) iridocorneal ang
98 ibose (dR) and one dR groups will screen for ICLs as modified dinucleosides; the accurate mass neutra
99                                       Higher ICL yields were observed for compounds with OCH(3) (3b),
100 aster cross-linking reaction rate and higher ICL efficiency than the corresponding 2-nitro analogues.
101 f XPF-ERCC1, RPA and SNM1A might explain how ICL unhooking is achieved in vivo.
102 nd the immunomodulatory effects of rhIL-7 in ICL patients.
103  that a high prevalence of autoantibodies in ICL, some of which are specific for CD4+ T cells, may co
104 ining an efficient SLX4-XPF-ERCC1 complex in ICL repair.
105  constitutive factor in the SLX4 complex, in ICL repair.
106 at PTEN and FANCD2 function cooperatively in ICL repair.
107                                   Defects in ICL repair result in Fanconi anemia, which is characteri
108 on protein A (RPA), show profound defects in ICL repair.
109 rovide insight into the mechanism of FAN1 in ICL repair and demonstrate that the Fan1 mouse model eff
110      We also establish that PTEN function in ICL repair is dependent on its protein phosphatase activ
111 nucleases, and the DOG-1 (FANCJ) helicase in ICL resolution, influenced by the replicative-status of
112 sent a promising therapeutic intervention in ICL.
113 y or the Slx4-Slx1 nuclease also involved in ICL repair.
114 -1) and transcription-coupled (CSB-1) NER in ICL sensing were exposed.
115  Xenopus extracts, how NEIL3 participants in ICL repair in human cells and its corporation with the c
116 ceptor (TCR) signaling have been reported in ICL, but the mechanistic and causative links remain uncl
117 Cdc48/VCP segregase plays a critical role in ICL repair by unloading the CMG complex from chromatin.
118               No obvious or critical role in ICL repair was seen for non-homologous end-joining (cku-
119 BRCA1 and BRCA2 also play important roles in ICL repair.
120 gs identify a premature T-cell senescence in ICL that might be caused by chronic T-cell activation an
121 ecifically introduces negative supercoils in ICL-containing plasmids in HeLa cell extracts.
122                                The increased ICL sensitivity of PTEN-deficient cells is caused, in pa
123  in human cells, and its depletion increases ICL-induced mutagenesis in human cells without altering
124 cover replication-dependent and -independent ICL repair networks, and establish nematodes as a model
125  advance our understanding of FA-independent ICL repair and establish a role for the RecQ4 helicases
126 f BRCA1, NUMB, or HES1 or chemically induced ICL damage in primary murine luminal MECs results in per
127 be recruited to localized trioxsalen-induced ICL damage in human cells, with accumulation being suppr
128  to cleave psoralen- and abasic site-induced ICLs in Xenopus egg extracts.
129  abolish interaction with RFWD3 also inhibit ICL repair, demonstrating that RPA-mediated RFWD3 recrui
130     The heat stability study of the isolated ICL products indicated that dGs were the preferred alkyl
131 rument deploys two interband cascade lasers (ICL) with center wavelengths of 4.3 and 4.4 mum.
132 using mid-infrared interband cascade lasers (ICLs) is a sensitive technique for trace gas sensing.
133 e.g., Cu(3) Sn) intermetallic coating layer (ICL) is rationally designed to stabilize Sn through a st
134  after 2 years of implantable collamer lens (ICL) V4c (STAAR Surgical AG, Nidau, Switzerland) placeme
135     Importance: Intraocular collamer lenses (ICLs) are posterior chamber phakic lenses that provide a
136 substrate containing a nitrogen mustard-like ICL two nucleotides in the duplex region because FAN1, u
137  show that FAN1 was able to degrade a linear ICL substrate.
138                      Interstrand cross-link (ICL) hypersensitivity is a characteristic trait of Fanco
139  is required for DNA interstrand cross-link (ICL) repair and is thus central to the maintenance of ge
140 uring eukaryotic DNA interstrand cross-link (ICL) repair, cross-links are resolved ("unhooked") by nu
141 her constitute a DNA interstrand cross-link (ICL) repair, or the FA pathway.
142 N1's function in DNA interstrand cross-link (ICL) repair.
143 y lethal lesion are interstrand cross-links (ICL), a property exploited by several anti-cancer chemot
144 ooking highly toxic interstrand cross-links (ICLs) and bulky minor groove adducts normally recognized
145                 DNA interstrand cross-links (ICLs) are a form of DNA damage that requires the interpl
146                     Interstrand cross-links (ICLs) are extremely toxic DNA lesions that create an imp
147                     Interstrand cross-links (ICLs) are highly cytotoxic DNA lesions that block DNA re
148                 DNA interstrand cross-links (ICLs) are repaired in S phase by a complex, multistep me
149 sDNA) and unhooking interstrand cross-links (ICLs) at fork structures.
150                 DNA interstrand cross-links (ICLs) block replication fork progression by inhibiting D
151 rsensitivity to DNA interstrand cross-links (ICLs) but not whole-body irradiation.
152 l for repairing DNA interstrand cross-links (ICLs), but the underlying mechanisms are unclear.
153 ity to generate DNA interstrand cross-links (ICLs), which effectively block the progression of transc
154 ively to repair DNA interstrand cross-links (ICLs).
155 d for repair of DNA interstrand cross-links (ICLs).
156 ectly producing DNA interstrand cross-links (ICLs).
157 very of fluorescent indocarbocyanine lipids (ICLs, DiR, DiD, DiI) as a model lipophilic cargo, via di
158 interaction profile near intracellular loop (ICL) 2/TM3 at the G-protein-coupling interface, suggesti
159 epducin for the beta2AR, intracellular loop (ICL)1-9, was used to decouple beta-arrestin-biased signa
160            In contrast, intracellular loops (ICLs) and C-terminalresidues exited the ribosome into a
161 lalanine (azF) into the intracellular loops (ICLs) and the C-tail of AT1R.
162 e of the glyoxylate shunt, isocitrate lyase (ICL), may mediate survival of Mtb during the acute and c
163                            Isocitrate lyase (ICL, types 1 and 2) is the first enzyme of the glyoxylat
164      Idiopathic CD4+ T cell lymphocytopenia (ICL) is a heterogeneous syndrome presenting with persist
165                  Idiopathic CD4 lymphopenia (ICL) is a rare syndrome defined by low CD4 T-cell counts
166        BACKGROUNDIdiopathic CD4 lymphopenia (ICL) is defined by persistently low CD4+ cell counts (<3
167  and general utility of glycosylase-mediated ICL repair in other bacteria are unknown.
168            In bacteria, glycosylase-mediated ICL unhooking was described in Streptomyces as a means o
169  4 (RECQL4), as a component of Pso2-mediated ICL repair.
170         Comparison of YcaQ and UvrA-mediated ICL resistance mechanisms establishes base excision as a
171  78 patients undergoing consecutive V4 model ICL implantations, which took place from January 1, 1998
172 enses implanted were as follows: 53 V4 model ICLs of -15.5 D or greater, 73 V4 model ICLs of less tha
173 odel ICLs of -15.5 D or greater, 73 V4 model ICLs of less than -15.5 diopter (D), and 7 V4 model tori
174 d a panel of model unhooked nitrogen mustard ICLs to systematically investigate how the state of an u
175                                  We observed ICL-induced chromosomal breakage in 9 of 17 (53%) HNSCC
176                         Approximately 30% of ICL patients develop autoimmune disease.
177                               Application of ICL-1 in a model of systemic bacterial infection reveals
178 to be an important long-term complication of ICL implantation.
179 d in the defective hematopoietic function of ICL-repair deficient myeloid progenitors.
180 oxylate levels using a chemical inhibitor of ICL restored growth of MS-deficient Mtb, despite inhibit
181              Following systemic injection of ICL-labeled cells in immunodeficient or immunocompetent
182 ase, or "unhook", ICLs, but the mechanism of ICL unhooking remains largely unknown.
183         Moreover, compensatory mechanisms of ICL resistance when FANCJ is deficient have not been exp
184 ir potential contribution to pathogenesis of ICL remain unclear.METHODSWe hybridized 34 and 51 ICL pa
185                          The pathogenesis of ICL remains unclear, and whether effector sites are also
186 tion and represents the preferred pathway of ICL repair in a vertebrate cell-free system.
187               The Fanconi anaemia pathway of ICL repair is activated when a replication fork stalls a
188 of NER and DSB/R (P <0022), similar rates of ICL/R, and more condensed chromatin structure compared w
189  rates of NER and DSB/R, comparable rates of ICL/R, more condensed chromatin structure, and higher se
190 d toxic joint DNA molecules during repair of ICL-induced DNA damage.
191                           Deep sequencing of ICL repair products showed that the approach and extensi
192 o report that unloading of RPA from sites of ICL induction is perturbed in RFWD3-deficient cells.
193 eby preventing RFWD3 recruitment to sites of ICL-induced replication fork stalling.
194  implicate MERIT40 in the earliest stages of ICL repair and define specific functional interactions b
195  shown to be necessary in the early steps of ICL repair to prevent aberrant nuclease resection, the r
196  pathways; however, a clear understanding of ICL recognition and repair processing in human cells is
197 lication forks stall, even in the absence of ICLs.
198 roduce metabolites that promote formation of ICLs leading to inhibition of trypanosomal growth.
199 ors that protect against the genotoxicity of ICLs generated by trioxsalen/ultraviolet A (TMP/UVA) dur
200                         Most measurements of ICLs lack sensitivity and structural information.
201                                    Repair of ICLs requires sequential incisions, translesion DNA synt
202 ng the mechanisms of base excision repair of ICLs.
203 ecruitment, CSA itself localized at sites of ICLs, DSBs and monoadducts but not at oxidative lesions.
204 onitored protein assembly and disassembly on ICL-containing chromatin.
205 d disease; it also brings a renewed focus on ICL that will likely result in improved diagnostic evalu
206 ation of the classical complement pathway on ICL CD4+ T cells.RESULTSAll ICL patients had a multitude
207 , HMGB1 functions in association with XPA on ICLs and facilitates the formation of a favorable archit
208 vault height (distance between the posterior ICL surface and anterior lens surface) measured a mean (
209        Thus, Fan1 nuclease activity promotes ICL repair in a manner that controls ploidy, a role that
210  in principle explain how Ub-Fancd2 promotes ICL repair, but we show that recruitment of Fan1 by Ub-F
211 ) protein bound to triplex-directed psoralen ICLs (TFO-ICLs) in vitro, cooperatively with NER damage
212  with both NEIL3 and FA pathways in psoralen-ICL repair, suggesting that TRAIP may function upstream
213 unction within the NEIL3 pathway in psoralen-ICL repair.
214 /BRCA pathways are non-epistatic in psoralen-ICL repair.
215 hway is the major pathway to repair psoralen-ICL through a unique DSB-free mechanism in human cells.
216  is the major pathway for repairing psoralen-ICL, and the FA/BRCA pathway is only activated when NEIL
217 hanistically, NEIL3 is recruited to psoralen-ICL in a rapid, PARP-dependent manner.
218 ortantly, the NEIL3 pathway repairs psoralen-ICLs without generating double-strand breaks (DSBs), unl
219        We report the synthesis of a putative ICL repair intermediate that mimics the complete process
220 g on the altered protein's ability to repair ICL damage.
221 epair (NER), interstrand cross-links repair (ICL/R), double-strand breaks repair (DSB/R), and chromat
222 TbSNM1, a nuclease that specifically repairs ICLs, are hypersensitive to most ABQ prodrugs, a phenoty
223 ement pathway on ICL CD4+ T cells.RESULTSAll ICL patients had a multitude of autoantibodies mostly di
224 makes identical strong bonds with these same ICLs.
225  activity, caused by elongation of the short ICL-unhooked oligonucleotide (a six-mer in our study) by
226 itro from Jurkat cells resulted in a similar ICL delivery as the injection of intact Jurkat cells.
227 that while purified XPF-ERCC1 incises simple ICL-containing model replication fork structures, the pr
228 oking mechanism for psoralen and abasic site ICLs.
229                The low activity of the Cu-Sn ICL against lithiation/delithiation enables the gradual
230 a result, the Sn anode enhanced by the Cu-Sn ICL shows a significant improvement in cycling stability
231 tion of the metallic Cu phase from the Cu-Sn ICL, which provides a regulatable and appropriate distri
232 on nuclease activity through a site-specific ICL in vitro We noted that stimulation of Pso2 nuclease
233       Here, we use repair of a site-specific ICL in Xenopus egg extracts to study the mechanism of le
234 fore, NBD2 might be critical for stabilizing ICLs 2 and 3 that form a tetrahelix bundle at the NBD2 i
235 tcomes of toric implantable collamer lens (T-ICL) with toric Artiflex (T-Artiflex) lenses.
236 endothelial loss of 2.18% and 1.95% in the T-ICL and T-Artiflex groups, respectively.
237 f success as large as 0.25 +/- 0.22 in the T-ICL group and 0.24 +/- 0.15 in the T-Artiflex group.
238 safety index was mean 1.40 +/- 0.70 in the T-ICL group and 1.20 +/- 0.21 in the T-Artiflex group.
239            A total of 39 eyes (95%) in the T-ICL group and 41 eyes (100%) in the T-Artiflex group wer
240 study compared 82 eyes of 41 patients with T-ICL lenses in one eye and toric Artiflex implantation in
241 bound to triplex-directed psoralen ICLs (TFO-ICLs) in vitro, cooperatively with NER damage recognitio
242 ons and facilitated error-free repair of TFO-ICLs in mouse fibroblasts.
243 re, we demonstrate that HMGB1 recognizes TFO-ICLs in human cells, and its depletion increases ICL-ind
244 ospective single center study indicates that ICL implantation provides good long-term safety and stab
245                        Our results show that ICL repair and replication termination both utilize a si
246 focal microscopy of intact BM confirmed that ICLs are delivered independently of the injected cells.
247 P residue was faithfully inserted across the ICL-G by Pol eta, Pol zeta, and Rev1-Pol zeta.
248  eta stalled just after insertion across the ICL.
249 icient human cells significantly altered the ICL-induced mutation spectrum from predominantly T-->A t
250  alone showed a tendency to stall before the ICL, whereas Pol eta stalled just after insertion across
251 cised the substrate predominantly beyond the ICL and, therefore, failed to release the 5' flap.
252  nick, NEIL3 targets both DNA strands in the ICL without generating single-strand breaks.
253                                 Instead, the ICL is unhooked when one of the two N-glycosyl bonds for
254 n fatty acids accumulated high levels of the ICL aldehyde endproduct, glyoxylate, and increased level
255 l of these pathways require unhooking of the ICL from one strand of a DNA duplex by nucleases, follow
256                               Removal of the ICL lesions is vital, as they are physical barriers to e
257 versal, are not an integral component of the ICL repair, pointing to a different mechanism of fork pr
258 e strand of the duplex on either side of the ICL.
259    The stalling of Pol eta directly past the ICL is attributed to its autoinhibitory activity, caused
260  stalling by Rev1-Pol zeta directly past the ICL was observed, suggesting that the proposed function
261 ing strand of a replication fork strikes the ICL Here, we report that while purified XPF-ERCC1 incise
262 h variation of DNA sequences showed that the ICL reaction occurred with opposing dG/dC but not with s
263 rticle particle formation was not due to the ICL labeling or complement attack and was observed after
264 ver, the recruitment of XPA and HMGB1 to the ICLs is co-dependent.
265                  Inefficient repair of these ICL can lead to leukemia and bone marrow failure.
266 of the non-ubiquitinated ID complex bound to ICL DNA-which we also report here-we show that monoubiqu
267 -associated nuclease 1 (FAN1) contributes to ICL repair, FAN1 mutations predispose to karyomegalic in
268 e mutagenic DNA repair following exposure to ICL-inducing agents.
269             MERIT40 was rapidly recruited to ICL lesions prior to FANCD2, and Merit40-null cells exhi
270                               In response to ICL V4c implant, considerable angle narrowing was detect
271 arrying BRCA2 DBD mutations are sensitive to ICL-inducing agents but resistant to HU treatment consis
272 for the initial rapid recruitment of FAN1 to ICLs or for its role in DNA ICL resistance.
273  is central to the pathway, and localizes to ICLs dependent on its monoubiquitination.
274 lso required for ICL repair, is recruited to ICLs by ubiquitinated (Ub) Fancd2.
275 ed for cellular and organismal resistance to ICLs.
276 than -15.5 diopter (D), and 7 V4 model toric ICLs for myopia.
277             This ability of FAN1 to traverse ICLs in DNA could help to elucidate its biological funct
278 ordinates multiple endonucleases that unhook ICLs, resolve homologous recombination intermediates, an
279 for the incisions that release, or "unhook", ICLs, but the mechanism of ICL unhooking remains largely
280 lly investigate how the state of an unhooked ICL affects pol eta activity.
281 length of the duplex surrounding an unhooked ICL critically affects polymerase efficiency.
282 imics the complete processing of an unhooked ICL to a single crosslinked nucleotide, and find that it
283 ucleases, followed by bypass of the unhooked ICL by translesion synthesis (TLS) polymerases.
284 n intermediates, and perhaps remove unhooked ICLs.
285               The structures of the unhooked ICLs remain unknown, yet the position of incisions and p
286  of incisions and processing of the unhooked ICLs significantly influence the efficiency and fidelity
287                                   Unrepaired ICL damage results in aberrant transdifferentiation to a
288  from Fan1(nd/nd) mice become polyploid upon ICL induction, suggesting that defective ICL repair caus
289                              In vertebrates, ICL repair is triggered when replication forks collide w
290                                       Visian ICL implantation improves visual function in special nee
291  achieved by sulcus implantation of a Visian ICL (STAAR Surgical, Monrovia, California, USA) under ge
292 unilateral intraocular collamer lens (Visian ICL) implantation for moderate to high myopia.
293  However, between 5 and 10% of BM cells were ICL-positive.
294        Treatment of Fan1-deficient mice with ICL-inducing agents results in pronounced thymic and bon
295  mucosal biopsy specimens from patients with ICL and healthy controls were evaluated.
296 uman IL-7 (rhIL-7) per week in patients with ICL who were at risk of disease progression.
297        These data suggest that patients with ICL, despite gut mucosal lymphopenia and local tissue in
298 vated in the colonic mucosa of patients with ICL.
299 was preserved in the mucosa of patients with ICL.
300 depletion sensitized cells to treatment with ICL-inducing agents and led to accumulation of cells in

 
Page Top